Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
ZIOPHARM ONCOLOGY INC See All Filings	D	2019-09-17 08:31:16 UTC
Amount To Be Raised $19,515,153 Associated Brokers / Dealers N/A CIK Number 0001107421 Filed Document 0001107421-19-000002 Exclusions or Exemptions 506b Accepted Date 2019-09-17 08:31:16 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Option To Acquire
ZIOPHARM ONCOLOGY INC See All Filings	D	2019-08-09 16:26:02 UTC
Amount To Be Raised $105,106,064 Associated Brokers / Dealers Raymond James & Associates, Inc. CIK Number 0001107421 Filed Document 0001107421-19-000001 Exclusions or Exemptions 506b Accepted Date 2019-08-09 16:26:02 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Option To Acquire
ZIOPHARM ONCOLOGY INC See All Filings	D	2018-11-19 16:33:19 UTC
Amount To Be Raised $107,007,575 Associated Brokers / Dealers Raymond James & Associates, Inc. CIK Number 0001107421 Filed Document 0001107421-18-000001 Exclusions or Exemptions 506b Accepted Date 2018-11-19 16:33:19 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
ZIOPHARM ONCOLOGY INC See All Filings	D	2016-07-07 16:36:22 UTC
Amount To Be Raised $120,000,000 Associated Brokers / Dealers N/A CIK Number 0001107421 Filed Document 0001107421-16-000004 Exclusions or Exemptions 506b Accepted Date 2016-07-07 16:36:22 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
ZIOPHARM ONCOLOGY INC See All Filings	D	2015-01-28 00:00:00 UTC
Amount To Be Raised $57,500,000 Associated Brokers / Dealers N/A CIK Number 0001107421 Filed Document 0001107421-15-000002 Exclusions or Exemptions 506b Accepted Date 2015-01-28 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity